ResultsHealthcare & Life Sciences
Portea revenue FY25: Rs 160 Cr, net loss Rs 19 Cr
Portea narrows FY25 loss to Rs 19 Cr on revenue growth
By Abha Lohia · Editor ·
Portea revenue
Portea reported revenue of Rs 160 Cr in FY25, with a net loss of Rs 19 Cr, as reported by Entrackr on 16 January 2026.
| Revenue (FY25) | Rs 160 Cr |
|---|---|
| Net loss (FY25) | Rs 19 Cr |
Portea: revenue and funding and every story →
Bengaluru
- Portea provides home healthcare services in India
- FY25 revenue rose 15% to Rs 160 Cr while the net loss shrank by 49% to Rs 19 Cr
- The company has raised $123 Mn but has not taken further steps toward its approved IPO
What happened
- Portea reported a Rs 19 Cr net loss for fiscal year 2025.
- This represents a significant 49% improvement compared to the Rs 37 Cr loss in FY24.
- Total revenue increased by 15% year-on-year to reach Rs 160 Cr.
- Service revenue grew by 16% to contribute Rs 95 Cr to operating income.
- Product sales revenue rose by 14% to account for Rs 56 Cr.
- Employee benefit costs decreased slightly by 4.5% to Rs 52.5 Cr.
- Consultancy expenses increased by 7% totaling Rs 44 Cr.
- Cost of materials jumped by 21% to reach Rs 52 Cr.
Why it matters
- The company maintains an approved Rs 1,000 Cr IPO authorization from SEBI since 2023.
- No further listing steps have been initiated despite the regulatory approval.
- Portea has accumulated approximately $123 Mn in total funding from investors.
- Accel and Ventureast are lead investors in the company's history.
The business
- Portea operates as a Bengaluru-based home healthcare services provider.
- Service revenue constitutes 59% of the company's total operating income.
- Product sales make up the remaining portion of the revenue mix.
- Advertisement expenses rose by 25% to Rs 7.5 Cr in FY25.
- Total expenses remained flat at Rs 179 Cr despite revenue growth.
- The company holds Rs 68 Cr in current assets as of March 2025.
- Cash and bank balances stood at just Rs 1 Cr during the period.
In numbers
Rs 19 CrNet Loss · FY25
Rs 160 CrRevenue · FY25
Rs 95 CrService Revenue · FY25
Rs 56 CrProduct Sales Revenue · FY25
-40.54%ROCE · FY25
-6.88%EBITDA Margin · FY25
Words to know
- ROCE
- Return on Capital Employed measures how efficiently a company uses its capital to generate profits.
- EBITDA
- Earnings Before Interest, Taxes, Depreciation, and Amortization shows operational profitability before non-cash items.
The numbers around it
Healthcare & Life Sciences in January 2026: 12 rounds with a disclosed amount, $99.0 million in all; the biggest was Sukino ($31M). Every sector this year →
Terms in this story
- IPO: An IPO, or initial public offering, is the first time a company sells its shares to the public and lists on a stock exchange. In India SEBI supervises it and the shares trade on the NSE and BSE. A retail investor can bid up to ₹2 lakh, and the issue stays open for three working days.
- Financial year: An Indian financial year runs from 1 April to 31 March, and it is named after the year it ends. FY26 means April 2025 to March 2026. Startup results for a year arrive months after it closes, so a November 2026 story may still be about FY25.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on Portea → · All startup news on 16 January 2026 →
Is this Portea? Get your “Featured on StopDown” badge →